slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,117
Current window 25,081-25,110
Pages 1,371
Rows per page 30
Component
25,081-25,110 of 41,117
02
23andMe | Investor Presentation Deck | 63 slides23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the scale of the 23andMe database and its application across three business pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
12
The slide uses a circular process flow to represent a self-reinforcing business model.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
13
The slide showcases three core product features using mobile and web UI screenshots.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The slide highlights the breadth of genetic reporting and emphasizes FDA authorizations.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
28
The slide uses a contrast-pair framework to highlight the competitive advantage of 23andMe over the traditional industry.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a grid of metrics for general health conditions and a timeline for the COVID-19 study.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
41
Includes a clinical trial flow diagram and endpoint table. Mentions strategic collaboration with GSK.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
47
The slide outlines a standard clinical trial design including patient criteria, cohort structure (Part A/B), and primary/secondary objectives.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
56
The table shows a significant increase in Advertising and Brand spend year-over-year.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
57
The table provides a breakdown of segment revenue and EBITDA, followed by a detailed reconciliation of non-GAAP measures.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
06
The table reconciles GAAP to non-GAAP income before taxes, provision for income taxes, and net income attributable to 3M.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations 1 hit
09
Includes a footnote explaining the non-GAAP definition of Net Debt.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations 1 hit
13
The slide uses a split layout with text on the left and a corporate image on the right.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Beat · Attention1 hit
22
The slide uses imagery to represent each business segment alongside its annual revenue.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
51
The slide uses a donut chart to visualize the revenue composition of the Health Care business unit.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
65
The slide highlights the segment's strategy of solving customer challenges through technology platform integration.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
79
The slide uses a bar chart to show cash flow performance and a list to explain the operational drivers.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
91
Includes disclaimer regarding pending divestiture of Food Safety business.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations 1 hit
15
The slide uses a stacked bar chart to distinguish between programs with and without downstream participation.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
21
The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Pegzilarginase Program OverviewLoop · Jobs To Be Done1 hit
27
Includes MCID thresholds for GMFM-E (GMFCS I and II).Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
02
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
03
Aeva | Results Presentation Deck | 16 slidesAeva | Results Presentation Deck | 16 slides · Aeva
Conference presentation Investor relations 1 hit
27
Slide 27 of a pitch deck. Contains three distinct chart/image panels showing efficacy of VGL101.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
28
PoM = Proof of Mechanism; ALSP = Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
33
Includes footnotes regarding clinical trial status and regulatory expectations.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
43
The slide uses a hub-and-spoke diagram to visualize the market opportunity for a platform technology targeting microglial function.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
46
The slide presents histological images and quantitative dot plots comparing Trem2 wild-type, heterozygous, and knockout mice.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
52
The slide uses a checklist format to indicate progress, with the first item marked as completed.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit